Furthermore, the anti-CD24 mAb, G7 mAb, enhances the inhibitory effect of cetuximab on tumor proliferation in vivo, suggesting that CD24 might promotes the growth of tumor cells through the regulation of EGFR expression (63). This evidence concerns the gene CD24 and neoplasm.